Lamivudine/nevirapine/stavudine - Emcure PharmaceuticalsAlternative Names: Lamivudine/stavudine/nevirapine - Emcure Pharmaceuticals; Nevirapine/lamivudine/stavudine - Emcure Pharmaceuticals; Nevirapine/stavudine/lamivudine - Emcure Pharmaceuticals; Stavudine/lamivudine/nevirapine - Emcure Pharmaceuticals; Stavudine/nevirapine/lamivudine - Emcure Pharmaceuticals
Latest Information Update: 27 Jul 2015
At a glance
- Originator Emcure Pharmaceuticals
- Class Antiretrovirals; Dideoxynucleosides; Nucleosides; Pyrimidine nucleosides
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration HIV-1 infections